+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Coagulant"

Hypofibrinogenemia - Pipeline Insight, 2024 - Product Thumbnail Image

Hypofibrinogenemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Coagulants are a type of hematological drug used to treat and prevent excessive bleeding. They work by helping the body form clots to stop bleeding. Coagulants are used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. They are also used to prevent excessive bleeding during surgery and childbirth. Coagulants are available in both oral and injectable forms. The coagulant market is a rapidly growing segment of the hematological drug market. It is driven by the increasing prevalence of bleeding disorders, the growing demand for safer and more effective treatments, and the development of new drugs. The market is expected to continue to grow in the coming years, driven by the increasing demand for coagulants and the development of new drugs. Some of the major companies in the coagulant market include Bayer AG, Pfizer Inc., Novo Nordisk A/S, Sanofi S.A., and CSL Behring. Show Less Read more